LEO Reports 16-week Results of Tralokinumab in P-III ECZTRA 6 Trial for the Treatment of Moderate-to-Severe Atopic Dermatitis Published: 22 Oct, 2021 | Tags: LEO, Tralokinumab, P-III, ECZTRA 6 Trial, […]readmore
Tags : Lipocine
Shots: Lipocine to receive $11.0M up front, $5.0M as licensing fees in Jan’25 & $5.0M in Jan’26, ~$160.0M as sales-based commercial milestone based on Tlando net sales, if Antares exercises […]readmore